Scientists discover how colon cancer cells change identity to spread
Billy Candra The discovery, published on June 22 in the esteemed journal Cell Stem Cell, represents a...
breast cancer
Artificial Intelligence Shows Promise in Early Detection of Interval Breast Cancers, UCLA Study Reveals
A groundbreaking new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center...
AI-human task-sharing could cut mammography screening costs by up to 30%
A groundbreaking study, recently published in the esteemed journal Nature Communications, asserts that a "delegation"...
Bilateral Salpingo-Oophorectomy Significantly Reduces Early Mortality and Secondary Cancer Risk in BRCA1/2 Carriers with Breast Cancer
A groundbreaking study by Cambridge researchers, published in The Lancet Oncology, has provided crucial evidence...
Salk Institute Uncovers Estrogen-Related Receptors as Potent Drivers for Muscle Energy Repair, Offering New Hope for Metabolic Disorders
A groundbreaking study from the Salk Institute, published in Proceedings of the National Academy of...
New Treatment Approach Achieves 100% Survival in Aggressive Inherited Breast Cancers, Cambridge Researchers Announce
A groundbreaking treatment strategy has dramatically improved survival rates for patients battling aggressive forms of...
Genetics and therapy type determine second cancer risk after childhood treatment
This significant finding, emerging from pioneering research conducted by scientists at St. Jude Children’s Research...
New genetic test can diagnose brain tumors in as little as two hours
This revolutionary diagnostic approach, detailed in a new study published today in the prestigious journal...
Federally Funded Trial Identifies and Eradicates Dormant Breast Cancer Cells, Offering Hope for Relapse Prevention
A groundbreaking, federally funded clinical trial has unveiled a revolutionary approach to combating breast cancer...
Doctors just found a way to slow one of the deadliest prostate cancers
Published in the esteemed journal Nature Medicine, the Phase III AMPLITUDE trial rigorously evaluated whether...
